Dandekar Atul
Known title: CSBOCIK: 0002050167
Associated companies
Transaction History
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 9/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,500 | $203K | 9/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,207 | $83K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 36 | $929 | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 391 | $11K | 9/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,800 | $74K | 9/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 12,500 | $0 | 9/1/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 8/28/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,500 | $207K | 8/28/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 7/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,100 | $194K | 7/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 400 | $11K | 7/29/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 6/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,500 | $210K | 6/29/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 5/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,500 | $198K | 5/29/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 8,320 | $87K | 5/4/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 5,985 | $62K | 5/4/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 4/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 7,500 | $190K | 4/29/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 3/30/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 6,710 | $196K | 3/30/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 790 | $24K | 3/30/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 2/27/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,739 | $169K | 2/27/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,761 | $172K | 2/27/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 7,500 | $78K | 1/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,200 | $52K | 1/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 3,500 | $154K | 1/29/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,800 | $126K | 1/29/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 100 | $1K | 12/30/2025 | View on chart |
| MAZE | ▼ Sell | Open Market | 100 | $4K | 12/30/2025 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 72,400 | $754K | 12/29/2025 | View on chart |
| MAZE | ▼ Sell | Open Market | 66,365 | $2.7M | 12/29/2025 | View on chart |
| MAZE | ▼ Sell | Open Market | 6,035 | $248K | 12/29/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pompe Disease Market Expected to Grow Through 2036
A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.
Pompe Disease Market Expected to Grow Through 2036. A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.